IDO1 and chronic myelogenous leukemia, BCR-ABL1 positive: Vonka et al. assessed IDO activity in CML patients’ samples by measuring the kynurenine/tryptophan ratio in serum, demonstrating a correlation between increased kynurenine levels and leukemia burden which decreased during therapy with interferon γ [109].